Myocardial Protection of Exenatide in AMI

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Experimental evidence suggests exenatide, a glucagon-like peptide 1 receptor analogue, has significant cardiovascular protective effects in various conditions. The investigators examined whether conventional use of exenatide at the time of primary percutaneous coronary intervention would reduce the infarct size in patients with ST-segment elevation myocardial infarction (STEMI).
Epistemonikos ID: 94a70a87c3d0ef09194c8acf97b8adbb02dc025e
First added on: May 10, 2024